These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1227746)

  • 1. [Preventive treatment of B type hemophilia: comparative evaluation between plasma and a concentrate of factor IX].
    Tribalto M; De Rossi G; Criscuolo D; Roseo I; Guarino S
    Clin Ter; 1975 Aug; 74(3):259-63. PubMed ID: 1227746
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of a new concentrate for the treatment of factor IX deficiency.
    Gilchrist GS; Ekert H; Shanbrom E; Hammond D
    N Engl J Med; 1969 Feb; 280(6):291-5. PubMed ID: 5762370
    [No Abstract]   [Full Text] [Related]  

  • 3. Variability of in vivo recovery of factor IX after infusion of monoclonal antibody purified factor IX concentrates in patients with hemophilia B. The Mononine Study Group.
    White GC; Shapiro AD; Kurczynski EM; Kim HC; Bergman GE
    Thromb Haemost; 1995 May; 73(5):779-84. PubMed ID: 7482403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemophilia. New aspects in diagnosis and treatment].
    Gormsen J
    Ugeskr Laeger; 1973 Nov; 135(46):2487-93. PubMed ID: 4592776
    [No Abstract]   [Full Text] [Related]  

  • 5. Haemophilia.
    Biggs R
    Proc R Soc Med; 1969 Sep; 62(9):913-4. PubMed ID: 4241884
    [No Abstract]   [Full Text] [Related]  

  • 6. Congenital deficiency of plasma thromboplastin component (PTC-factor IX): report of 25 cases from 19 unrelated families.
    Agarwal MB; Mehta BC
    J Assoc Physicians India; 1982 Jan; 30(1):17-9. PubMed ID: 6820363
    [No Abstract]   [Full Text] [Related]  

  • 7. Zero incidence of inhibitors in previously untreated patients who received intermediate purity factor VIII concentrate or factor IX complex.
    Schimpf K; Schwarz P; Kunschak M
    Thromb Haemost; 1995 Mar; 73(3):553-5. PubMed ID: 7667845
    [No Abstract]   [Full Text] [Related]  

  • 8. Surgical operation in hemophilia B. Use of factor IX concentrate.
    Kasper CK
    Calif Med; 1970 Jul; 113(1):4-8. PubMed ID: 5520728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat treated New Zealand factor IX concentrate: comparison with Prothrombinex in patients with haemophilia B.
    Benny AG; Ockelford PA; Johns AS; Woodfield DG; Berry EW
    N Z Med J; 1986 Jun; 99(803):408-9. PubMed ID: 3461352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of hemophilias].
    Fischer M; Deutsch E
    Dtsch Med J; 1968 Jul; 19(14):499-505. PubMed ID: 5305713
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of haemophilia B with purified Factor IX (PPSB).
    Loeliger EA; Hensen A; Mattern MJ; Veltkamp JJ; Bruning PF; Hemker HC
    Folia Med Neerl; 1967; 10(4):112-25. PubMed ID: 6073947
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of hemophilia].
    Stavem P; Hjort PF
    Tidsskr Nor Laegeforen; 1970 Jul; 90(13):1413-8. PubMed ID: 5453192
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and efficacy of purified factor IX concentrate and antifibrinolytic agents for dental extractions in hemophilia B.
    Djulbegovic B; Marasa M; Pesto A; Kushner GM; Hadley T; Joseph G; Goldsmith G
    Am J Hematol; 1996 Feb; 51(2):168-70. PubMed ID: 8579061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transfusion therapy of hemophilia A and B].
    Egli H
    Bibl Haematol; 1967; 27():204-10. PubMed ID: 5595089
    [No Abstract]   [Full Text] [Related]  

  • 15. Implantation of autologous skin fibroblast genetically modified to secrete clotting factor IX partially corrects the hemorrhagic tendencies in two hemophilia B patients.
    Qiu X; Lu D; Zhou J; Wang J; Yang J; Meng P; Hsueh JL
    Chin Med J (Engl); 1996 Nov; 109(11):832-9. PubMed ID: 9275366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The situation of hemophiliacs in Sweden].
    Nilsson IM
    Lakartidningen; 1981 Dec; 78(52):4725-8. PubMed ID: 6799720
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and efficacy of monoclonal antibody purified factor IX concentrate in previously untreated patients with hemophilia B.
    Shapiro AD; Ragni MV; Lusher JM; Culbert S; Koerper MA; Bergman GE; Hannan MM
    Thromb Haemost; 1996 Jan; 75(1):30-5. PubMed ID: 8713776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Substitution therapy of coagulopathies].
    Beeser H; Egli H
    Infusionstherapie (1973); 1974 Aug; 1(6):447-53. PubMed ID: 4466806
    [No Abstract]   [Full Text] [Related]  

  • 19. Towards gene therapy for hemophilia B.
    Anson DS; Hock RA; Austen D; Smith KJ; Brownlee GG; Verma IM; Miller AD
    Mol Biol Med; 1987 Feb; 4(1):11-20. PubMed ID: 3475525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic transfusion for hypertrophic synovitis in children with hemophilia.
    Greene WB; McMillan CW; Warren MW
    Clin Orthop Relat Res; 1997 Oct; (343):19-24. PubMed ID: 9345200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.